SCHEDULE: Ionic Ventures Discloses 9.9% Stake in BioTricity

Ionic Ventures LLC and affiliated entities have updated their Schedule 13G filing to report beneficial ownership of 3,096,987 shares of BioTricity Inc. common stock, representing 9.9% of the outstanding shares.

Summary

• Ionic Ventures LLC, along with Ionic Management, LLC, Brendan O'Neil, and Keith Coulston, have filed an amendment (Amendment No. 7) to their Schedule 13G.
• The filing reports beneficial ownership of 3,096,987 shares of BioTricity Inc. common stock.
• This ownership represents 9.9% of the company's outstanding common stock as of February 11, 2026.
• The reported shares include 532,757 shares of common stock directly or indirectly held.
• Additionally, the ownership includes up to 2,564,230 shares issuable upon conversion of Series B Convertible Preferred Stock.
• Conversions are subject to a 9.99% beneficial ownership limitation (the 'Blocker') as per the company's Amended Certificate of Designations.
• Certain conversions are also limited due to restrictions on the number of conversion notices within a specific period.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily an update on ownership and conversion limitations rather than a strategic announcement or financial performance update.

Positives

• The reporting persons collectively hold a significant stake of 9.9% in BioTricity Inc., indicating substantial investor interest.
• The ownership structure includes direct holdings and potential conversion of preferred stock, offering flexibility.

Negatives

• The beneficial ownership is capped at 9.99% due to a 'Blocker' provision, limiting further conversion of preferred stock.
• Additional conversion of preferred stock is restricted by limitations on conversion notices within a 60-day period.

Risks

• The 9.99% beneficial ownership limitation ('Blocker') restricts the ability to increase ownership through preferred stock conversion.
• Limitations on the number of conversion notices within a 60-day period could impact the timing and extent of future share acquisition.
• The reliance on preferred stock conversion means the actual number of common shares held is subject to the terms of the Certificate of Designations.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from BioTricity Inc. It primarily details the current ownership structure and limitations on future conversions of preferred stock by the reporting persons.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by Ionic Ventures and associated parties indicates a significant passive investment in BioTricity Inc., a company operating in the digital health or medical device sector. Such filings are common for institutional investors or significant shareholders seeking to comply with disclosure requirements.

Stakeholder Impact

• Shareholders: The filing clarifies the ownership structure and potential dilution from preferred stock conversion, which is capped. This provides transparency regarding the significant stake held by Ionic Ventures and its affiliates.

Next Steps

• The reporting persons will continue to monitor their beneficial ownership in BioTricity Inc.
• Future actions may depend on BioTricity Inc.'s performance and strategic decisions, within the constraints of the 'Blocker' provision.

Key Dates

Keywords

BioTricity Inc., Schedule 13G, Ionic Ventures LLC, Beneficial Ownership, Convertible Preferred Stock, SEC Filing, Amendment, Blocker Provision, Shareholder